Cargando…

SUN-174 Severe Insulin Resistance and Diabetic Ketoacidosis after Brentuximab Vendotin and Cyclosporin Treatment

Introduction: Brentuximab Vendotin(BV) is antibody-drug conjugate that selectively delivers cytotoxic agent, monomethyl auristatin E, targeting cells expressing surface CD30, treatment approved for refractory Hodgkin’s lymphoma. Previous research suggested MDR1 inhibition (cyclosporine) can overcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyunju, Reijonen, Helena, King, Victoria, Salehian, Behrouz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552905/ http://dx.doi.org/10.1210/js.2019-SUN-174

Ejemplares similares

SUN-LB029 A Case of Gestational Diabetes with Diabetic Ketoacidosis, Insulin Injection Site Reaction and Anti Insulin Antibodies in Pregnancy
por: Hakimian, Stephanie, et al.
Publicado: (2019)

SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019)

SUN-700 Fournier’s Gangrene and Diabetic Ketoacidosis Caused by Canagliflozin
por: Stamatiades, George Alexiades, et al.
Publicado: (2020)

SUN-LB036 Diabetic Ketoacidosis: A Rare Side Effect of Nivolumab Induced Insulin Dependent Diabetes Mellitus
por: Abid, Haisam, et al.
Publicado: (2019)

SUN-LB025 Superior Mesenteric Artery Thrombosis: An Uncommon Complication of Diabetic Ketoacidosis
por: Saini, Khushpreet Kaur, et al.
Publicado: (2019)

SUN-183 Prolonged Glycosuria after Canagliflozin Discontinuation in a Patient with Euglycemic Diabetic Ketoacidosis
por: Dai, Yufei, et al.
Publicado: (2019)

SUN-167 Quetiapine-Induced Hypertriglyceridemia and Hyperglycemia Presenting as Simultaneous Diabetic Ketoacidosis and Acute Pancreatitis
por: Gandhi, Shriya, et al.
Publicado: (2019)

SUN-173 Nivolumab-Induced Fulminant Autoimmune Diabetes Presenting as Diabetic Ketoacidosis in a Patient with Melanoma
por: Parikh, Sahil, et al.
Publicado: (2019)

SUN-182 When Insulin Is Not Enough...
por: DiCenso, Daniela, et al.
Publicado: (2019)

SUN-188 Contributing Factors Precipitation Diabetic Ketoacidosis in Patients Using Sodium-Glucose Cotransporter-2 Inhibitor
por: Attia, Jonven, et al.
Publicado: (2019)

SUN-178 A Not So "Sweet" DKA: A Case of Euglycemic Diabetic Ketoacidosis Caused by Dapagliflozin/Liraglutide Combination
por: Sideri Gugger, Aristea, et al.
Publicado: (2019)

SUN-172 Diabetic Ketoacidosis Precipitated by Treatment with PD-1 Inhibitor: A Rare Immune Related Adverse Event
por: Qureshi, Mohammed
Publicado: (2019)

SUN-179 Prolonged Hypoglycemia from Insulin Degludec
por: Kothari, Vallari, et al.
Publicado: (2019)

SUN-615 Does Patient Location (Urban or Rural) Influence Risk Factors and Incidence Rate for 30-Day Readmission for Diabetic Ketoacidosis?
por: Varghese, Ron Thomas, et al.
Publicado: (2020)

SUN-186 Insulin Antibody Associated Severe Insulin Resistance Leading to Uncontrolled Hyperglycemia
por: Amir, Hajira, et al.
Publicado: (2019)

SUN-166 Insulin Dose Calculator in a Pediatric Hospital
por: Shaaban, Sarah, et al.
Publicado: (2019)

SUN-649 Metabolic and Functional Regulation of T Cells by Insulin and Insulin like Growth Factor 1
por: Kiernan, Kaitlin, et al.
Publicado: (2020)

SUN-125 Role of Various Insulin Assays in the Diagnosis of Factitious Hypoglycemia
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2019)

Diabetic Ketoacidosis With Alpelisib
por: Jeun, Rebecca, et al.
Publicado: (2021)

SUN-176 Euglycemic Diabetic Ketoacidosis withSGLT2 Inhibitor Presenting as Chest Pain in a Patient with Coronary Artery Disease on a Ketogenic Diet
por: Dorcely, Brenda, et al.
Publicado: (2019)

SUN-673 Development of Euglycemic Diabetic Ketoacidosis in a Patient with Well-Controlled Type 2 Diabetes Mellitus on a Sodium-Glucose Transporter 2 Inhibitor
por: Narang, Disha K, et al.
Publicado: (2020)

SUN-151 Improved Glycemic Control with Automated Insulin Pump (AIP) Technology
por: Amole, Morolake, et al.
Publicado: (2019)

SUN-697 Importance of Immunosuppressive Therapy for Managing Insulin Resistance Type B
por: Amankwah, Samuel, et al.
Publicado: (2020)

SUN-685 Approach to a Potential Liver Transplant Candidate with Insulin Antibody-Mediated Severe Insulin Resistance
por: Brooks, Danielle C, et al.
Publicado: (2020)

SAT-174 Loss of CEACAM1 in Endothelial Cells Causes Hepatic Fibrogenesis
por: Muturi, Harrison, et al.
Publicado: (2019)

Alpelisib-Induced Diabetic Ketoacidosis
por: Espinosa, Luis Borges, et al.
Publicado: (2021)

SUN-127 Diabetic Ketoacidosis Unmasking Glucose-6-Phosphate Dehydrogenase Deficiency in a 25-Year-Old Male with Diabetes Mellitus Type 2: A Case Report
por: Santiago, Aivind Gabrielle, et al.
Publicado: (2019)

MON-128 Pneumomediastinum in Diabetic Ketoacidosis
por: Poudel, Resham, et al.
Publicado: (2019)

SUN-627 A Test for Variation in Insulin Concentrations at the Wilford Hall Ambulatory and Surgical Center
por: Jenkins, Craig, et al.
Publicado: (2020)

SUN-670 P300 and CBP Are Necessary for Skeletal Muscle Insulin-Stimulated Glucose Uptake
por: Martins, Vitor Fernandes, et al.
Publicado: (2020)

SUN-630 Insulin Pumps Versus Multiple Daily Injections in Type 1 Diabetic Pregnancies
por: Albanese, Isabella, et al.
Publicado: (2020)

MON-675 Ziprasidone Induced Diabetic Ketoacidosis
por: Thanikonda, Varshitha, et al.
Publicado: (2020)

SAT-670 The Perfect Storm for Diabetic Ketoacidosis
por: Abushamat, Layla A, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor
por: Manas, F N U, et al.
Publicado: (2021)

SUN-160 Insulin Glargine Time of Injection during Fasting Ramadan in Patients with Type 1 Diabetes
por: Alamoudi, Reem, et al.
Publicado: (2019)

SUN-658 CHL1 Increases Insulin Secretion&Negatively Regulates the Poliferation of Pancreatic β Cell
por: Yang, Tao, et al.
Publicado: (2020)

SUN-644 Effects of Steroid Hormones on Lipogenesis and Insulin Sensitivity - an Insight into the Involvement of the Wnt Signaling Pathway
por: Alex, Neethu Sara, et al.
Publicado: (2020)

SUN-681 Does Short Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Mellitus Delay Eventual Insulin Dependence
por: Patil, Madhuri, et al.
Publicado: (2020)

MON-174 Type II Diabetics Decrease Hypertensive Medication and Improve Blood Pressure in 18 Days
por: Michel, Rebecca, et al.
Publicado: (2019)

SUN-147 Sarcopenia Is Associated with the Degree of Insulin Resistance and Risk of Type 2 Diabetes in Older Age Group
por: Son, Jang Won, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qti6hmtsn4dkdbontkinobp8vl